Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene
about
Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and BImpaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberinFMRP S499 is phosphorylated independent of mTORC1-S6K1 activity.The role of stem cells in skeletal and cardiac muscle repair.Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarctionCardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice.Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex.Modulation of the cardiomyocyte cell cycle in genetically altered animals.Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapyCell-based approaches for cardiac repair.Cardiac myocyte cell cycle control in development, disease, and regeneration.Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repressionOrgan repair and regeneration: an overview.Synaptic plasticity and learning in animal models of tuberous sclerosis complex.Recent advances in heart regeneration.Tuberin negatively affects BCL-2's cell survival function.Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta elicit opposing effects on Rap1GAP stability.Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.
P2860
Q28205432-73F9D3BA-FC7D-42B4-99A4-0A11A97FBED3Q30459608-FB1CC6C1-B3E8-4E57-9C77-49E7A0795243Q33578330-8AC35F09-F2EB-40C0-8408-DD8E05FDC31FQ34124836-A6245785-060F-49D7-8666-8F92B860396BQ34488508-F9577760-9792-427D-8B74-19D540E946EBQ34725406-073B5686-1732-4360-814E-FEB09B3797E5Q34784347-60DD3FE6-98ED-4280-92A8-F75AB0AF4353Q35009587-51678B78-8CC3-415E-9256-BB940B39A47FQ35748464-BEBEC0E5-7F9E-470A-8D09-24E07D79B8C2Q35807721-C0E1A2CF-7A41-4D74-A715-6918FA65D94BQ35940027-BCB590D0-D97B-4884-BD09-9D31CEE7031CQ36667275-8E9C052A-0993-4B1D-9099-3049B3E38502Q36788885-8CBEE59E-024C-415C-B4BC-8531B432D8F8Q36812158-ABC6F13E-8D24-47DB-8329-54B005193276Q37997980-40476064-1BC2-422D-8C7A-BD03C6E843EEQ38030915-B118ACB2-7E3F-47C7-B6C8-3B59E0BEF4E2Q38147034-72ED2F0F-154F-457C-B2A1-E9EE56C57AC1Q40268081-F5D24E28-6BF6-49E7-BFFF-A274E68261F4Q40609778-394BE6BE-1435-42B1-9F48-6F0FEDBD16C9Q40749976-415165B5-7470-4F4A-BFB2-4F7FC010CE3EQ42523255-378B01A8-91B6-4878-9E5A-0D854546F65FQ42822932-007F3DA2-D196-413A-BA6C-D07EE52914A0Q43718788-D67FA4E7-3194-4603-AA2E-BF3972F2FA30Q47588810-E540D0B6-991E-4389-8FE4-F07A34B7CCDD
P2860
Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene
description
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Mai 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/05/26)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/05/26)
@nl
наукова стаття, опублікована в травні 2000
@uk
مقالة علمية (نشرت في 26-5-2000)
@ar
name
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@ast
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@en
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@nl
type
label
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@ast
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@en
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@nl
prefLabel
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@ast
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@en
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@nl
P2093
P1433
P1476
Enhanced cardiomyocyte DNA syn ...... sing a modified TSC2 transgene
@en
P2093
H. Nakajima
H. O. Nakajima
K. B. Pasumarthi
L. J. Field
P304
P356
10.1161/01.RES.86.10.1069
P577
2000-05-26T00:00:00Z